iBio
IBIO
$1.99
Share price
-1.97%
Change (1 day)
80.91%
Change (1 year)
Categories
iBio (IBIO) - Total assets
Total assets on the balance sheet as of December 2023 : $34.02 M
According to iBio's latest financial reports the company's total assets are $34.02 M. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
iBio - Total assets on balance sheet (from 2008 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2023-06-30 | $41.2 M | -58.55% |
| 2022-06-30 | $99.4 M | -32.36% |
| 2021-06-30 | $0.14 B | 56.04% |
| 2020-06-30 | $94.18 M | 207.95% |
| 2019-06-30 | $30.58 M | -29.01% |
| 2018-06-30 | $43.08 M | 19.64% |
| 2017-06-30 | $36.01 M | -30.21% |
| 2016-06-30 | $51.6 M | 313% |
| 2015-06-30 | $12.49 M | 92.39% |
| 2014-06-30 | $6.49 M | -30.58% |
| 2013-06-30 | $9.35 M | -4.21% |
| 2012-06-30 | $9.76 M | 33.11% |
| 2011-06-30 | $7.33 M | 48.79% |
| 2010-06-30 | $4.93 M | -0% |
| 2009-06-30 | $4.93 M | 38.91% |
| 2008-06-30 | $3.54 M | -5.81% |
| 2007-06-30 | $3.76 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $167.55 B | 492,398.97% | 🇺🇸 USA |
 Genocea Biosciences
GNCA | $38.78 M | 14.01% | 🇺🇸 USA |
 Nektar Therapeutics
NKTR | $0.39 B | 1,069.93% | 🇺🇸 USA |
 Emergent BioSolutions
EBS | $1.82 B | 5,258.89% | 🇺🇸 USA |